CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-19 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,787,155 | ||
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −9,821 | $195.31 | $1.9M | 5,442,125 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −5,948 | $196.84 | $1.2M | 5,436,177 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −15,554 | $197.58 | $3.1M | 5,420,623 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −851 | $198.46 | $169K | 5,419,772 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −1,475 | $199.94 | $295K | 5,418,297 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −1,501 | $200.82 | $301K | 5,416,796 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −900 | $202.20 | $182K | 5,415,896 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −1,020 | $203.06 | $207K | 5,414,876 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −300 | $204.13 | $61K | 5,414,576 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −1,758 | $205.20 | $361K | 5,412,818 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Sale | −872 | $206.50 | $180K | 5,411,946 |
| 2023-01-18 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,827,155 | ||
| 2023-01-18 | AFEYAN NOUBAR Director | Sale | −10,000 | $200.20 | $2.0M | 2,247,209 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Sale | −800 | $181.32 | $145K | 5,451,146 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Sale | −5,411 | $182.43 | $987K | 5,445,735 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Sale | −4,389 | $183.42 | $805K | 5,441,346 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Sale | −8,900 | $184.32 | $1.6M | 5,432,446 |
Page 60 of 66 · 1,314 trades